Gabriel N. Hortobágyi

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplemental Figure 3 from Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Figshare(2023)10.1158/0008-5472.22378737.v1

Top 100%

0DataRank

Top 100%0 citations

Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee +22 more

Papers

Driven by 40 papers — median percentile 0. Top paper: “TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis”.

TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis

Journal of Clinical Investigation(2021)10.1172/jci139434

N/A

7.4DataRank · unranked

314 citations

Seung-Oe Lim, Meisi Yan, Jennifer L. Hsu, Jun Yao, Yongkun Wei +12 more

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(22)00739-2

N/A

2.0DataRank · unranked

102 citations

Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders +16 more

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0144

N/A

2.0DataRank · unranked

79 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment

Frontiers in Oncology(2020)10.3389/fonc.2020.01197

N/A

1.6DataRank · unranked

58 citations

Jennifer L. Hsu, Yintao Li, Gabriel N. Hortobágyi, Mien‐Chie Hung, Zhou Jiang

Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3100

N/A

1.3DataRank · unranked

42 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer

eLife(2021)10.7554/elife.65145

N/A

1.1DataRank · unranked

34 citations

Amin Hajitou, Wouter H. P. Driessen, Bettina Proneth, Marina Cardó‐Vila, Daniela I. Staquicini +25 more

Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7062

N/A

0.883DataRank · unranked

27 citations

Gary Zirpoli, William E. Barlow, G. Thomas Budd, Bryan McKiver, Lajos Pusztai +10 more

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.101817

N/A

0.815DataRank · unranked

21 citations

Li-Chuan Chan, Ying‐Nai Wang, Yu‐Yi Chu, Chie‐Hong Wang, Heng‐Huan Lee +17 more

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.02344

N/A

0.646DataRank · unranked

17 citations

Jieling Miao, Lajos Pusztai, Matthew P. Goetz, Priya Rastogi, Patricia A. Ganz +17 more

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)

Biomarkers(2023)10.1080/1354750x.2023.2168063

N/A

0.587DataRank · unranked

12 citations

Adrian Nordmark, Amy Williams, Costanza Paoletti, William E. Barlow, Erin F. Cobain +11 more

Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1001

N/A

0.587DataRank · unranked

49 citations

Eve T. Rodler, William E. Barlow, Julie R. Gralow, Shannon Leigh Huggins-Puhalla, Carey K. Anders +15 more

Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial

npj Breast Cancer(2023)10.1038/s41523-023-00535-0

N/A

0.498DataRank · unranked

11 citations

Yalai Bai, Vasiliki Pelekanou, Zeina Nahleh, Saba Shafi, Sneha Burela +12 more

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1562

N/A

0.457DataRank · unranked

20 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae314

N/A

0.443DataRank · unranked

10 citations

William E. Barlow, Julie R. Gralow, Funda Meric‐Bernstam, Kathy S. Albain, Daniel F. Hayes +19 more

Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0330

N/A

0.373DataRank · unranked

11 citations

Gaurav B. Chauhan, Ramakrishna Edupuganti, Takahiro Kogawa, Jihyun Park, Moises Tacam +20 more

Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma

European Journal of Cancer(2023)10.1016/j.ejca.2023.113250

N/A

0.313DataRank · unranked

5 citations

Akshara Singareeka Raghavendra, Roland L. Bassett, Matthias Christgen, Lavinia P. Middleton, Mediget Teshome +6 more

Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy

Investigational New Drugs(2023)10.1007/s10637-023-01357-4

N/A

0.285DataRank · unranked

5 citations

Ryan Sun, Roland L. Bassett, Lei Huo, Jeffrey T. Chang, Mediget Teshome +24 more

Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221

Research Square(2023)10.21203/rs.3.rs-3242513/v1

N/A

0.104DataRank · unranked

1 citations

Gary Zirpoli, G. Thomas Budd, William E. Barlow, Lajos Pusztai, Gabriel N. Hortobágyi +8 more

Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1076

N/A

0DataRank · unranked

0 citations

William E. Barlow, Costanza Paoletti, Mattias Bergqvist, Amy Williams, Hanna Ritzén +11 more

Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221

Cancer Chemotherapy and Pharmacology(2024)10.1007/s00280-024-04680-6

N/A

0DataRank · unranked

1 citations

Gary Zirpoli, G. Thomas Budd, William E. Barlow, Lajos Pusztai, Gabriel N. Hortobágyi +8 more

FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models

Journal of Clinical Investigation(2025)10.1172/jci173757

N/A

0DataRank · unranked

4 citations

Hirohito Yamaguchi, Yuan Gao, Weiya Xia, Jeffrey T. Chang, Yu‐Chun Hsiao +27 more

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2019.5559

N/A

0DataRank · unranked

78 citations

William E. Barlow, Reshma Jagsi, Thomas A. Buchholz, Steven Shak, Frederick L. Baehner +13 more

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial

UNC Libraries(2025)10.17615/dgtt-ap31

N/A

0DataRank · unranked

0 citations

Julie R. Gralow, Edith Perez, Kevin Kalinsky, Gabriel N. Hortobágyi, Nancy U. Lin +19 more

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

UNC Libraries(2020)10.17615/twk7-x350

N/A

0DataRank · unranked

0 citations

Victor Weigman, Nicholas J. Wang, Vicente Valero, Aňa Lluch, Jane Fridlyand +22 more

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation

Nature Communications(2021)10.1038/s41467-021-23075-2

N/A

0DataRank · unranked

31 citations

Ying‐Nai Wang, Wenhao Yang, Weiya Xia, Yongkun Wei, Li-Chuan Chan +25 more

Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex

Nature Cancer(2022)10.1038/s43018-022-00438-2

N/A

0DataRank · unranked

37 citations

Mei‐Kuang Chen, Yongkun Wei, Heng‐Huan Lee, Weiya Xia, Ying‐Nai Wang +21 more

Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02222

N/A

0DataRank · unranked

42 citations

Samantha M. Thomas, Daniel F. Hayes, Mariana Chávez‐MacGregor, Kimberly H. Allison, Jennifer De Los Santos +8 more

Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation

International Journal of Biological Sciences(2023)10.7150/ijbs.84592

N/A

0DataRank · unranked

38 citations

Heng‐Huan Lee, Zhou Jiang, Li-Chuan Chan, Gabriel N. Hortobágyi, Dihua Yu +2 more

Data from Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53–Mediated Mouse Mammary Tumors

(2023)10.1158/0008-5472.c.6497703

N/A

0DataRank · unranked

0 citations

Christopher R. Smith, Shuanzeng Wei, Yoon Kim, Gordon B. Mills, Gabriel N. Hortobágyi +3 more

Supplemental Figure 3 from Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Figshare(2023)10.1158/0008-5472.22378737.v1

Top 100%

0DataRank

Top 100%0 citations

Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee +22 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384.v1

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Data from Activation of FOXO3a Is Sufficient to Reverse Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor Chemoresistance in Human Cancer

(2023)10.1158/0008-5472.c.6500598

N/A

0DataRank · unranked

0 citations

Chun-Ju Chang, Weiya Xia, Yan Wang, Kwok‐Kin Wong, Jeffrey A. Engelman +5 more

Supplementary Table 4 from Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

(2023)10.1158/0008-5472.22378674

Top 100%

0DataRank

Top 100%0 citations

Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee +22 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597

N/A

0DataRank · unranked

0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532592

Top 100%

0DataRank

Top 100%0 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

Data from Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer

(2023)10.1158/1078-0432.c.6517681.v1

N/A

0DataRank · unranked

0 citations

Tiffany A. LaFortune, Savitri Krishnamurthy, Francisco J. Esteva, Massimo Cristofanilli, Ping Liu +6 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597.v1

N/A

0DataRank · unranked

0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Silencing Kinase-Interacting Stathmin Gene Enhances Erlotinib Sensitivity by Inhibiting Ser10 p27 Phosphorylation in Epidermal Growth Factor Receptor–Expressing Breast Cancer

(2023)10.1158/1535-7163.c.6531732.v1

N/A

0DataRank · unranked

0 citations

Ana M. Tari, Uǧur Akar, Banu Arun, Tiffany A. LaFortune, René Nieves-Alicea +3 more

Data from Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors

(2023)10.1158/1078-0432.c.6530691.v1

N/A

0DataRank · unranked

0 citations

Jiali Ji, Xiaolan Dai, Aiham Qdaisat, Francisco J. Esteva, Gabriel N. Hortobágyi +2 more

Gabriel N. Hortobágyi

Indexed papers

Top data-sharing exemplar

Papers